Original Articles (2016-)
- Sakugawa C, Haruyama Y, Tanaka H,Fukushima T, Kawaguchi M, Kataoka H.Prognostic significance of hepatocyte growth factor activator inhibitor type 1(HAI-1)immunoreactivity in pancreatic ductal adenocarcinoma. BMCResearch Notes, 10:674 (2017)
- Nonboe AW, Krigslund O, Soendergaard C, Skovbjerg S, Friis S, Andersen MN, Ellis V, Kawaguchi M, Kataoka H, Bugge TH, Vogel LK.HAI-2 stabilizes, inhibits, and regulates SEA-cleavage-dependent secretory transport of matriptase. Traffic, 18 : 378-391 (2017)
- Kanemaru A, Yamamoto K, Kawaguchi M, Fukushima T, Lin CY, Johnson MD, Camerer E, Kataoka H.Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer]associated fibroblasts by paracrine activation of protease]activated receptor 2. Int. J. Cancer, 140(1):130-141 (2016)
- Kawaguchi M, Yamamoto K, Kanemaru A, Tanaka H, Umezawa K, Fukushima T, Kataoka H.Inhibition of nuclear factor-ΘB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model. Oncotarget, 7:68614-68622 (2016)
- Inagaki-Ohara K, Okamoto S, Takagi K, Saito K, Arita S, Tang L, Hori T, Kataoka H, Matsumoto S, Minokoshi Y.Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice. Nutrition & Metabolism, 13:7 (2016)